Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate
- PMID: 17220729
- DOI: 10.1097/01.rli.0000251541.03822.bb
Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate
Abstract
Objectives: We sought to determine the localization accuracy using 3-dimensional (3D) proton magnetic resonance spectroscopic imaging (MRSI) of the entire prostate with a standardized thresholds approach in prostate cancer patients.
Materials and methods: In a prospective study, 32 consecutive patients were examined. Mean age and prostate specific antigen level were 61 years and 7.8 ng/mL, respectively. Median biopsy Gleason score was 6. T2-weighted MRI and 3D MRSI of the entire prostate were performed. Three readers recorded the location of suspicious peripheral zone and central gland cancer nodules on a standardized division of the prostate (14 regions of interest [ROI]) using a standardized thresholds approach. The degree of diagnostic confidence for each ROI was recorded on a 5-point scale. Reconstructed whole-mount section histopathology was the standard of reference. The sensitivity, specificity, positive, and negative predictive value, overall accuracy and interobserver agreement were calculated. Areas under the ROI-based receiver operating characteristic curve (AUC) and diagnostic performance parameters were determined.
Results: The standardized thresholds approach had an accuracy of 81% and an AUC of 0.85-0.86 for differentiation between benign and malignant ROIs in the peripheral zone and an accuracy of 87% and an AUC of 0.86-0.91 for this differentiation in the central gland, respectively. Specificities of 81% to 88% were achieved with accompanying sensitivities of 75% to 92% for both peripheral zone and central gland, respectively. Moderate to near-perfect interobserver agreement was demonstrated (kappa=0.42-0.91).
Conclusion: Our data indicate that a standardized zone-specific threshold approach in MRSI of the prostate is able to prospectively differentiate between benign and malignant tissues in the peripheral zone and the central gland with good accuracy and interobserver agreement.
Similar articles
-
The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels.BJU Int. 2009 Mar;103(6):730-3. doi: 10.1111/j.1464-410X.2008.08205.x. Epub 2009 Jan 14. BJU Int. 2009. PMID: 19154475 Review.
-
Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours.Clin Radiol. 2008 Aug;63(8):871-9. doi: 10.1016/j.crad.2007.10.020. Clin Radiol. 2008. PMID: 18625351
-
Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging.Radiology. 2006 Nov;241(2):449-58. doi: 10.1148/radiol.2412051866. Epub 2006 Sep 11. Radiology. 2006. PMID: 16966484
-
Prostate cancer: value of magnetic resonance spectroscopy 3D chemical shift imaging.Abdom Imaging. 2006 Jul-Aug;31(4):490-9. doi: 10.1007/s00261-006-9029-8. Abdom Imaging. 2006. PMID: 16955379 Review.
-
Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy.Radiology. 2004 Jan;230(1):215-20. doi: 10.1148/radiol.2301021562. Radiology. 2004. PMID: 14695396
Cited by
-
Improving the Effective Spatial Resolution in 1H-MRSI of the Prostate with Three-Dimensional Overdiscretized Reconstructions.Life (Basel). 2023 Jan 19;13(2):282. doi: 10.3390/life13020282. Life (Basel). 2023. PMID: 36836640 Free PMC article.
-
Developments in proton MR spectroscopic imaging of prostate cancer.MAGMA. 2022 Aug;35(4):645-665. doi: 10.1007/s10334-022-01011-9. Epub 2022 Apr 20. MAGMA. 2022. PMID: 35445307 Free PMC article. Review.
-
Proton MRS of cervical cancer at 7 T.NMR Biomed. 2019 Jan;32(1):e4015. doi: 10.1002/nbm.4015. Epub 2018 Oct 30. NMR Biomed. 2019. PMID: 30376201 Free PMC article.
-
Characterization of prostate cancer with MR spectroscopic imaging and diffusion-weighted imaging at 3 Tesla.Magn Reson Imaging. 2019 Jan;55:93-102. doi: 10.1016/j.mri.2018.08.025. Epub 2018 Aug 31. Magn Reson Imaging. 2019. PMID: 30176373 Free PMC article.
-
Metabolic Imaging in Prostate Cancer: Where We Are.Front Oncol. 2016 Nov 9;6:225. doi: 10.3389/fonc.2016.00225. eCollection 2016. Front Oncol. 2016. PMID: 27882307 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical